Aarti Pharmalabs Ltd.

The quarter ended December 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 3730.30 millions.Good  Net Profit growth of 25.04% reported above the corresponding previous quarter figure of Rs. 385.40 millions to Rs. 481.90 millioins.OP of the company witnessed a marginal growth to 884.80 millions from 726.00 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202312	202212	% Var	202312	202212	% Var	202303	202203	% Var
Sales	3730.30	3593.30	3.81	10873.10	11369.80	-4.37	15112.50	9410.20	60.60
Other Income	2.00	0.40	400.00	50.60	12.80	295.31	12.80	25.10	-49.00
PBIDT	884.80	726.00	21.87	2438.80	2328.10	4.75	3096.20	1822.90	69.85
Interest	41.00	51.20	-19.92	119.50	146.90	-18.65	204.90	113.40	80.69
PBDT	843.80	674.80	25.04	2319.30	2181.20	6.33	2891.30	1709.50	69.13
Depreciation	169.40	145.60	16.35	487.00	415.20	17.29	557.70	372.30	49.80
PBT	674.40	529.20	27.44	1832.30	1766.00	3.75	2333.60	1337.20	74.51
TAX	192.50	143.80	33.87	456.00	448.80	1.60	616.30	270.00	128.26
Deferred Tax	62.50	22.50	177.78	112.50	67.50	66.67	95.00	45.00	111.11
PAT	481.90	385.40	25.04	1376.30	1317.20	4.49	1717.30	1067.20	60.92
Equity	453.10	453.10	0.00	453.10	453.10	0.00	453.10	455.60	-0.55
PBIDTM(%)	23.72	20.20	17.40	22.43	20.48	9.54	20.49	19.37	5.76